Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical, Pathologic Characteristics and Its Mechansim of Denosumab Treated Giant Cell Tumor of Bone

NCT03259152 is registered in ClinicalTrials.gov with Hebei Medical University Third Hospital as lead sponsor.

NCT NCT03259152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03259152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical, Pathologic Characteristics and Its Mechansim of Denosumab Treated Giant Cell Tumor of Bone
Lead sponsor
Hebei Medical University Third Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
May 1, 2016
Completion date
May 1, 2019
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell tumor of bone